Eton Pharmaceuticals reported 3 months of 2022

Eton Pharmaceuticals' GAAP loss for 3 months of 2022 was $5.33 million, compared to a profit of $5.116 million in the previous year. Revenue decreased 5.47 times to $2.176 million from $11.897 million a year earlier.